Dietary Phosphorus Regulates Serum Fibroblast Growth Factor-23 Concentrations in Healthy Men
Abstract
CONTEXT: Fibroblast growth factor 23 (FGF-23) is important in the regulation of phosphorus and vitamin D metabolism. States of excess circulating FGF-23 are associated with renal phosphate wasting and inappropriately low serum 1,25-dihydroxyvitamin D [1,25(OH)(2)D] concentrations. Conversely, states of absent or biologically inactive circulating FGF-23 are associated with increased serum phosphorus and 1,25(OH)(2)D concentrations. Restriction of the dietary intake of phosphorus increases renal phosphate reabsorption and 1,25(OH)(2)D production, whereas the opposite occurs when dietary phosphorus is supplemented. OBJECTIVE: We sought to determine whether serum FGF-23 concentration is regulated by dietary phosphorus and thereby mediates the physiological response of serum 1,25(OH)(2)D to changes in dietary phosphorus. DESIGN, SETTING, AND PARTICIPANTS: We studied 13 healthy men as inpatients during a 4-wk dietary phosphorus intervention study. INTERVENTION: Subjects consumed a constant diet that provided 500 mg of phosphorus per day, which was supplemented to achieve three phosphorus intakes, each of 9 d: 1) control = 1500 mg/d; 2) supplemented = 2300 mg/d; 3) restricted = 625 mg/d. Intakes of calcium, sodium, potassium, magnesium, and energy were constant. MAIN OUTCOME MEASURE: Serum FGF-23, 1,25(OH)(2)D, phosphorus, and calcium concentrations were measured. RESULTS: Serum FGF-23 concentrations decreased significantly from 30.7 +/- 8.7 pg/ml during phosphorus supplementation to 19.6 +/- 7.0 pg/ml during phosphorus restriction. Serum 1,25(OH)(2)D concentrations increased significantly from 29 +/- 10 pg/ml (75 +/- 26 pmol/liter) during phosphorus supplementation to 40 +/- 16 pg/ml (104 +/- 42 pmol/liter) during phosphorus restriction (P < 0.001). Serum 1,25(OH)(2)D concentrations varied inversely with those of serum FGF-23 (r = -0.67, P < 0.001). CONCLUSIONS: We conclude that in healthy men, changes in dietary phosphorus within the physiological range of intakes regulate serum FGF-23 concentrations and suggest that dietary phosphorus regulation of 1,25(OH)(2)D production is mediated, at least in part, by changes in circulating FGF-23.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In mixed sex, intermediate-term studies, enteral and intravenous Pi loading increased serum Pi and PTH and decreased calcitriol.
“In mixed sex, intermediate-term studies, oral, enteral, or intravenous Pi loading increased iFGF23 and urinary Pi excretion, while enteral and intravenous Pi loading additionally increased serum Pi, and PTH, and decreased calcitriol [2, 20, 25, 50, 58].”
From Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels (2025) · cites this paper as [2]
In mixed sex, intermediate-term studies, oral, enteral, or intravenous Pi loading increased iFGF23 and urinary Pi excretion.
“In mixed sex, intermediate-term studies, oral, enteral, or intravenous Pi loading increased iFGF23 and urinary Pi excretion, while enteral and intravenous Pi loading additionally increased serum Pi, and PTH, and decreased calcitriol [2, 20, 25, 50, 58].”
From Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels (2025) · cites this paper as [2]
Cites
Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004) · Endocrinology · doi:10.1210/en.2004-0233 · Cited by 329 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III
Chang, A. R., Lazo, M., Appel, L. J., Gutiérrez, O. M., & Grams, M. E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.073148 · Cited by 262 · see citing works
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
Nishida, Y., Taketani, Y., Yamanaka-Okumura, H., Imamura, F., Taniguchi, A., Sato, T., Shuto, E., Nashiki, K., Arai, H., Yamamoto, H., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5002000 · Cited by 243 · see citing works
Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
Vervloet, M. G., van Ittersum, F. J., Büttler, R. M., Heijboer, A. C., Blankenstein, M. A., & ter Wee, P. M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04730510 · Cited by 218 · see citing works
Blau, J. E., Bauman, V., Conway, E. M., Piaggi, P., Walter, M. F., Wright, E. C., Bernstein, S., Courville, A. B., Collins, M. T., Rother, K. I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99123 · Cited by 172 · see citing works
Stubbs, J., Liu, S., & Quarles, L. D. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00308.x · Cited by 123 · see citing works
Scialla, J. J., Appel, L. J., Wolf, M., Yang, W., Zhang, X., Sozio, S. M., Miller, E. R., Bazzano, L. A., Cuevas, M., Glenn, M. J., et al. (2012) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2012.01.026 · Cited by 115 · see citing works
Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism
Gutiérrez, O. M., Luzuriaga-McPherson, A., Lin, Y., Gilbert, L. C., Ha, S.-W., & Beck, G. R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2279 · Cited by 82 · see citing works
Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels
Gerber, J. S., Arroyo, E. M. P., Pastor, J., Correia, M., Rudloff, S., Moe, O. W., Egli-Spichtig, D., Mohebbi, N., & Wagner, C. A. (2025) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03046-4 · Cited by 15 · see citing works
- Authors
- Antoniucci, D. M., Yamashita, T., & Portale, A. A.
- Affiliations
- Division of Endocrinology (D.M.A.), Takasaki 370-1295, Japan
- Kirin (Japan) (JP)
- University of California, San Francisco (US)
- Corresponding author
- Portale, Anthony A.
- ORCID
- Portale, Anthony A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-08-01
- Volume
- 91
- Issue
- 8
- Pages
- 3144-3149
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2164074621
- Cited by
- 421
- References
- 1
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 11 · 2023: 13 · 2022: 16 · 2021: 25 · 2020: 11 · 2019: 23 · 2018: 28 · 2017: 25 · 2016: 21 · 2015: 26 · 2014: 24 · 2013: 51 · 2012: 32
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
- Funders
- National Institutes of Health (5r01dk054433-05)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 54433)
- National Center for Research Resources (K23RR020343)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Vitamin D Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- fibroblast growth factor 23, dietary phosphorus, phosphate limitation, phosphorus supplementation, 1,25-dihydroxyvitamin D, vitamin D metabolism, serum phosphorus, calcium, renal phosphate reabsorption, healthy men, phosphate homeostasis
- MeSH terms
- Fibroblast Growth Factor-23, Adult, Calcitriol, Calcium, Fibroblast Growth Factors, Homeostasis, Humans, Male, Parathyroid Hormone, Phosphorus, Phosphorus, Dietary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review